Patent assignee · US · COMPANY

Calimmune, Inc.

3Patents
3Active
3Granted
44Portfolio score

Filing activity: Nov 2, 2017 → Jul 18, 2018

Most-cited patents

PatentTitleAreaCited byStatus
US10138495B2 Bio-production of lentiviral vectors Chemistry; Metallurgy 2 Active
US10426798B2 Modulatable switch for selection of donor modified cells Human Necessities 1 Active
US10240214B2 Methods for discriminating between HIV-1 and lentiviral vectors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.